📰 Confidence Interval News
Page 37 - Confidence Interval News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Confidence Interval. Real-time updates on events, politics, business and more.
August 4, 2022
As many as 60 per cent of adults believe they will have make cuts to their spending to be able to afford fuel this winter, a survey has found. The survey ...
August 3, 2022
As many as 60 per cent of adults believe they will have make cuts to their spending to be able to afford fuel this winter, a survey has found. The survey ...
July 14, 2022
New research released from The University of Georgia has recently provided a pathway to achieving a more simplified and cost-effective method for flood mapping that can account for the rising
July 8, 2022
1. Previous infection, vaccination, and hybrid immunity protected against infection with the omicron variant of coronavirus disease 2019 (COVID-19). 2. Hybrid immunity from previous infection and recent booster vaccination provided the strongest overall protection against the omicron variant. Evidence Rating Level: 1 (Excellent) Study Rundown: The omicron variant of SARS-CoV-2 was prevalent from late 2021
July 2, 2022
–Phase 2 trial showed chemotherapy-free TUKYSA combination resulted in clinically meaningful and durable tumor responses––Results presented in late-breaking oral session at the ESMO World Congress on Gastrointestinal Cancer–BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced full results from...
July 2, 2022
-Phase 2 trial showed chemotherapy-free TUKYSA combination resulted in clinically meaningful and durable tumor responses- -Results presented in late-breaking oral session at the ESMO World Congress
July 2, 2022
–Phase 2 trial showed chemotherapy-free TUKYSA combination resulted in clinically meaningful and durable tumor responses– –Results presented in late-b
June 27, 2022
In May 2018, following the preliminary results of a study in Botswana that reported congenital anomalies in babies born to HIV-positive women taking dolutegravir drug, the WHO issued a teratogenicity alert. However, there are scarce data on the impact of this guidance on contraceptive uptake among women taking dolutegravir. We assessed the uptake of contraceptives in HIV-positive women of reproductive age on dolutegravir regimens. We conducted a cross-sectional survey from April 2019 to July 201...
June 23, 2022
Maternal autoantibody–related autism spectrum disorder (MAR ASD) is marked by specific maternal antibodies that react to certain proteins in the fetal brain. Examining the plasma of expecting mothers, researchers found mothers with reactivity to one of the nine MAR ASD patterns were eight times as likely to have a child diagnosed with autism.